Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

21.05.25 15:40 Uhr

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.In addition to the Zacks Rank, investors looking for stocks with specific traits can utilize our Style Scores system. Of course, value investors will be most interested in the system's "Value" category. Stocks with "A" grades for Value and high Zacks Ranks are among the best value stocks available at any given moment.Tenet Healthcare (THC) is a stock many investors are watching right now. THC is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock has a Forward P/E ratio of 12.83. This compares to its industry's average Forward P/E of 13.66. Over the last 12 months, THC's Forward P/E has been as high as 16.94 and as low as 8.81, with a median of 13.31.Investors will also notice that THC has a PEG ratio of 1.19. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. THC's industry currently sports an average PEG of 1.41. Within the past year, THC's PEG has been as high as 1.45 and as low as 0.55, with a median of 0.82.Finally, investors should note that THC has a P/CF ratio of 6.93. This metric focuses on a firm's operating cash flow and is often used to find stocks that are undervalued based on the strength of their cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 7.54. Over the past 52 weeks, THC's P/CF has been as high as 6.93 and as low as 2.83, with a median of 3.77.These are only a few of the key metrics included in Tenet Healthcare's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, THC looks like an impressive value stock at the moment.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Quelle: Zacks

Nachrichten zu Tenet Healthcare Corp.

Wer­bung

Analysen zu Tenet Healthcare Corp.

DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
17.05.2012Tenet Healthcare overweightBarclays Capital
10.05.2012Tenet Healthcare overweightBarclays Capital
02.04.2012Tenet Healthcare overweightBarclays Capital
03.11.2011Tenet Healthcare overweightBarclays Capital
04.08.2011Tenet Healthcare overweightBarclays Capital
DatumRatingAnalyst
26.11.2012Tenet Healthcare neutralRobert W. Baird & Co. Incorporated
25.09.2012Tenet Healthcare neutralUBS AG
03.11.2011Tenet Healthcare sector performRBC Capital Markets
21.07.2010Tenet Healthcare neutralUBS AG
02.06.2010Tenet Healthcare DowngradeRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
28.01.2009Tenet Healthcare underperformRBC Capital Markets
01.10.2008Tenet Healthcare DowngradeUBS AG
08.11.2007Tenet Healthcare underweightLehman Brothers Inc.
08.11.2007Tenet Healthcare underperformCowen and Company, LLC
11.09.2007Tenet Healthcare underweightLehman Brothers Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Tenet Healthcare Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen